Information Provided By: 
Fly News Breaks for August 24, 2015
GEVO
Aug 24, 2015 | 11:40 EDT
Rodman & Renshaw believes the settlement agreement entered into between Gevo and Butamax not only removes the overhang and uncertainty that was hampering Gevo's marketing efforts for bio-based isobutanol, but also immediately frees up litigation dollars that can be used for better purposes. The firm reiterates its Buy rating and $5 price target on Gevo shares.
News For GEVO From the Last 2 Days
GEVO
Apr 25, 2024 | 08:53 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here
